Zero Relapses: New Bowel Cancer Treatment Shows Promise

A groundbreaking immunotherapy treatment for bowel cancer has resulted in zero relapses after 33 months, a dramatic improvement over standard care where 25% of patients see cancer return.

The UK trial offers hope for thousands of patients each year.